CNBC's "Fast Money" The Next Shoe To Drop In Office Space… And Insmed Surges On Drug Results 5/28/24
May 28, 2024
Exploring troubles in office real estate space, Insmed's stock surging on drug trial results, challenges in commercial real estate, United Airlines EPS guidance impact, Cava's earnings beat and growth potential, McDonald's stock performance, Nvidia's influence in chip sector, Dell as adjacent play to Nvidia, tax hike impact on sports gambling stocks, and innovative drug development opportunities.
AI Snips
Chapters
Transcript
Episode notes
Commercial Real Estate Concerns
- Office real estate trouble is worsening, especially in class B buildings.
- Loan modifications are increasing, but this is a short-term fix, transferring risk to the future.
Cashcarri's CRE Predictions
- Neil Cashcarri predicts big losses in commercial real estate, especially in London and New York.
- He wouldn't rule out a rate hike due to persistent inflation and economic strength.
Global Impact on Yields
- Rising yields in Japan put upward pressure on US Treasury yields, impacting mortgage rates.
- Poor Treasury auctions and higher yields create challenges for the commercial real estate market.